Old versus New: Why Do We Need New Antiepileptic Drugs?
Sang Kun Lee
J Epilepsy Res. 2014;4(2):39-44.   Published online 2014 Dec 31     DOI: https://doi.org/10.14581/jer.14010
Citations to this article as recorded by Crossref logo
Antiepileptic drug discontinuation by people with epilepsy in the general population
Giorgia Giussani, Elisa Bianchi, Valentina Canelli, Giuseppe Erba, Carlotta Franchi, Alessandro Nobili, Josemir W. Sander, Ettore Beghi
Epilepsia.2017; 58(9): 1524.     CrossRef
Clinical utility of topiramate extended-release capsules (USL255): Bioequivalence of USL255 sprinkled and intact capsule in healthy adults and an in vitro evaluation of sprinkle delivery via enteral feeding tubes
Annie M. Clark, John M. Pellock, Mary Holmay, Bob Anders, James Cloyd
Epilepsy & Behavior.2016; 57: 105.     CrossRef
Canine versus human epilepsy: are we up to date?
A. Uriarte, I. Maestro Saiz
Journal of Small Animal Practice.2016; 57(3): 115.     CrossRef
Quality-of-life aspects in idiopathic epilepsy in dogs
A. Wessmann, H. A. Volk, R. M. A. Packer, M. Ortega, T. J. Anderson
Veterinary Record.2016; 179(9): 229.     CrossRef
New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel
Leslie A Rudzinski, Naymeé J Vélez-Ruiz, Evan R Gedzelman, Elizabeth A Mauricio, Jerry J Shih, Ioannis Karakis
Journal of Investigative Medicine.2016; 64(6): 1087.     CrossRef
A pharmacological basis of herbal medicines for epilepsy
Nikolaus J. Sucher, Maria C. Carles
Epilepsy & Behavior.2015; 52: 308.     CrossRef
Music therapy as a non-pharmacological treatment for epilepsy
Huan Liao, Guohui Jiang, Xuefeng Wang
Expert Review of Neurotherapeutics.2015; 15(9): 993.     CrossRef